BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17049671)

  • 1. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.
    Edwards JG; Swinson DE; Jones JL; Waller DA; O'Byrne KJ
    Lung Cancer; 2006 Dec; 54(3):399-407. PubMed ID: 17049671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma.
    Edwards JG; Faux SP; Plummer SM; Abrams KR; Walker RA; Waller DA; O'Byrne KJ
    Clin Cancer Res; 2002 Jun; 8(6):1857-62. PubMed ID: 12060628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis is an independent prognostic factor in malignant mesothelioma.
    Edwards JG; Cox G; Andi A; Jones JL; Walker RA; Waller DA; O'Byrne KJ
    Br J Cancer; 2001 Sep; 85(6):863-8. PubMed ID: 11556838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.
    O'Byrne KJ; Edwards JG; Waller DA
    Lung Cancer; 2004 Aug; 45 Suppl 1():S45-8. PubMed ID: 15261433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma.
    Edwards JG; Swinson DE; Jones JL; Muller S; Waller DA; O'Byrne KJ
    Chest; 2003 Nov; 124(5):1916-23. PubMed ID: 14605068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma.
    O'Kane SL; Cawkwell L; Campbell A; Lind MJ
    Eur J Cancer; 2005 Jul; 41(11):1645-8. PubMed ID: 15964184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors.
    Kothmaier H; Quehenberger F; Halbwedl I; Morbini P; Demirag F; Zeren H; Comin CE; Murer B; Cagle PT; Attanoos R; Gibbs AR; Galateau-Salle F; Popper HH
    Thorax; 2008 Apr; 63(4):345-51. PubMed ID: 18086752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
    Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
    J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
    Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
    Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
    Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
    Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma.
    Zekri AR; Bahnassy AA; Mohamed WS; Hassan N; Abdel-Rahman AR; El-Kassem FA; Gaafar R
    Pathol Int; 2007 Aug; 57(8):493-501. PubMed ID: 17610473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.